These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

660 related items for PubMed ID: 16307805

  • 1. Simple criteria for differentiation of Fabry disease from amyloid heart disease and other causes of left ventricular hypertrophy.
    Hoigné P, Attenhofer Jost CH, Duru F, Oechslin EN, Seifert B, Widmer U, Frischknecht B, Jenni R.
    Int J Cardiol; 2006 Aug 28; 111(3):413-22. PubMed ID: 16307805
    [Abstract] [Full Text] [Related]

  • 2. [Hypertrophic cardiomyopathy with dilatation of the left ventricle and congestive heart failure: comparison with postmyocarditis cardiomegaly and hypertensive heart failure].
    Kawanishi H, Yokota Y, Hayakawa M, Kaku K, Kumaki T, Matsumoto K, Fujitani K, Ito Y, Inoh T, Fukuzaki H.
    J Cardiogr; 1983 Sep 28; 13(3):537-50. PubMed ID: 6235295
    [Abstract] [Full Text] [Related]

  • 3. Value of electrocardiogram in the differentiation of hypertensive heart disease, hypertrophic cardiomyopathy, aortic stenosis, amyloidosis, and Fabry disease.
    Namdar M, Steffel J, Jetzer S, Schmied C, Hürlimann D, Camici GG, Bayrak F, Ricciardi D, Rao JY, de Asmundis C, Chierchia GB, Sarkozy A, Lüscher TF, Jenni R, Duru F, Brugada P.
    Am J Cardiol; 2012 Feb 15; 109(4):587-93. PubMed ID: 22105784
    [Abstract] [Full Text] [Related]

  • 4. Differentiation of cardiac amyloidosis and hypertrophic cardiomyopathy. A comparison of familial amyloidosis with polyneuropathy and hypertrophic cardiomyopathy by electrocardiography and echocardiography.
    Eriksson P, Backman C, Eriksson A, Eriksson S, Karp K, Olofsson BO.
    Acta Med Scand; 1987 Feb 15; 221(1):39-46. PubMed ID: 3565084
    [Abstract] [Full Text] [Related]

  • 5. Fabry disease in patients with hypertrophic cardiomyopathy (HCM).
    Beer G, Reinecke P, Gabbert HE, Hort W, Kuhn H.
    Z Kardiol; 2002 Dec 15; 91(12):992-1002. PubMed ID: 12490989
    [Abstract] [Full Text] [Related]

  • 6. [Four cases of Fabry's disease mimicking hypertrophic cardiomyopathy].
    Tanaka H, Adachi K, Yamashita Y, Toshima H, Koga Y.
    J Cardiol; 1988 Sep 15; 18(3):705-18. PubMed ID: 2977798
    [Abstract] [Full Text] [Related]

  • 7. [Cardiological follow-up in patients with Fabry disease].
    Pieruzzi F, Pieroni M, Chimenti C, Frustaci A, Sarais C, Cecchi F, Area Cardiologica-Advisory Board Plan Multidisciplinare "Diagnosi e Follow-up Malattia di Fabry".
    G Ital Cardiol (Rome); 2010 Sep 15; 11(7-8):566-72. PubMed ID: 21033333
    [Abstract] [Full Text] [Related]

  • 8. Amyloidosis and cardiac involvement.
    Cacoub P, Axler O, De Zuttere D, Hausfater P, Amoura Z, Walter S, Wechsler B, Godeau P, Piette JC.
    Ann Med Interne (Paris); 2000 Dec 15; 151(8):611-7. PubMed ID: 11173703
    [Abstract] [Full Text] [Related]

  • 9. [Echocardiographic findings of a patient with cardiac amyloidosis and left ventricular outflow obstruction].
    Noma S, Akaishi M, Murayama A, Akiyama H, Ogawa S, Handa S, Nakamura Y, Sohma Y, Hosoda Y, Gotoh M.
    J Cardiogr; 1982 Mar 15; 12(1):267-78. PubMed ID: 6889625
    [Abstract] [Full Text] [Related]

  • 10. Left ventricular hypertrophy: cardiac magnetic resonance may help differentiate amyloidosis from hypertrophic cardiomyopathy.
    Mabru M, Dacher JN, Bauer F.
    Arch Cardiovasc Dis; 2010 Jan 15; 103(1):55-6. PubMed ID: 20142122
    [No Abstract] [Full Text] [Related]

  • 11. Terminal stage cardiac findings in patients with cardiac Fabry disease: an electrocardiographic, echocardiographic, and autopsy study.
    Takenaka T, Teraguchi H, Yoshida A, Taguchi S, Ninomiya K, Umekita Y, Yoshida H, Horinouchi M, Tabata K, Yonezawa S, Yoshimitsu M, Higuchi K, Nakao S, Anan R, Minagoe S, Tei C.
    J Cardiol; 2008 Feb 15; 51(1):50-9. PubMed ID: 18522775
    [Abstract] [Full Text] [Related]

  • 12. Cardiovascular manifestations in Fabry disease: a clinical and echocardiographic study.
    Sadick N, Thomas L.
    Heart Lung Circ; 2007 Jun 15; 16(3):200-6. PubMed ID: 17452128
    [Abstract] [Full Text] [Related]

  • 13. [M-mode and two-dimensional echocardiography of 7 cases of cardiac amyloidosis].
    Roudaut R, Haissaguerre M, Dallocchio M.
    Arch Mal Coeur Vaiss; 1984 Dec 15; 77(13):1525-31. PubMed ID: 6240237
    [Abstract] [Full Text] [Related]

  • 14. Glycogen storage diseases presenting as hypertrophic cardiomyopathy.
    Arad M, Maron BJ, Gorham JM, Johnson WH, Saul JP, Perez-Atayde AR, Spirito P, Wright GB, Kanter RJ, Seidman CE, Seidman JG.
    N Engl J Med; 2005 Jan 27; 352(4):362-72. PubMed ID: 15673802
    [Abstract] [Full Text] [Related]

  • 15. Multiparametric electrocardiographic evaluation of left ventricular hypertrophy in idiopathic and hypertensive cardiomyopathy.
    Lazzeri C, Barletta G, Badia T, Capalbio A, Del Bene R, Franchi F, Gensini GF, Michelucci A.
    Ital Heart J; 2005 Apr 27; 6(4):304-10. PubMed ID: 15902928
    [Abstract] [Full Text] [Related]

  • 16. MRI differentiation of cardiomyopathy showing left ventricular hypertrophy and heart failure: differentiation between cardiac amyloidosis, hypertrophic cardiomyopathy, and hypertensive heart disease.
    Takeda M, Amano Y, Tachi M, Tani H, Mizuno K, Kumita S.
    Jpn J Radiol; 2013 Oct 27; 31(10):693-700. PubMed ID: 23996116
    [Abstract] [Full Text] [Related]

  • 17. Hypertrophic cardiomyopathy complicated with cardiac amyloidosis.
    Kohno I, Komori S, Yamamoto K, Sano S, Ishihara T, Umetani K, Sawanobori T, Ijiri H, Tamura K.
    Intern Med; 2000 Aug 27; 39(8):637-40. PubMed ID: 10939537
    [Abstract] [Full Text] [Related]

  • 18. [Hypertrophic cardiomyopathy manifesting different modes of illness: report of three cases].
    Shida M, Miyazaki Y, Matsuyama K, Iwami G, Ooga M, Chiba M, Furuta Y, Toshima H, Koga Y.
    J Cardiol; 1987 Mar 27; 17(1):187-97. PubMed ID: 3429921
    [Abstract] [Full Text] [Related]

  • 19. Effects of enzyme replacement therapy on the cardiomyopathy of Anderson-Fabry disease: a randomised, double-blind, placebo-controlled clinical trial of agalsidase alfa.
    Hughes DA, Elliott PM, Shah J, Zuckerman J, Coghlan G, Brookes J, Mehta AB.
    Heart; 2008 Feb 27; 94(2):153-8. PubMed ID: 17483124
    [Abstract] [Full Text] [Related]

  • 20. Tricuspid annular motion velocity as a differentiation index of hypertrophic cardiomyopathy from hypertensive heart disease.
    Hayashi S, Yamada H, Nishio S, Hotchi J, Bando M, Takagawa Y, Saijo Y, Hirata Y, Sata M.
    J Cardiol; 2015 Jun 27; 65(6):519-25. PubMed ID: 25199979
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.